VF
SLS icon

Virtu Financial’s SELLAS Life Sciences SLS Stock Holding History

Virtu Financial’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-221,829
Closed -$938K – 2192
2026
Q1 		$938K Buy
+221,829
New +$992K 0.04% 324
2025
Q2 		– Sell
-53,861
Closed -$58K – 1999
2025
Q1 		$58K Buy
53,861
+12,706
+31% +$15.1K ﹤0.01% 995
2024
Q4 		$43K Sell
41,155
-38,086
-48% -$43.5K ﹤0.01% 1184
2024
Q3 		$99K Buy
79,241
+15,398
+24% +$18.8K 0.01% 913
2024
Q2 		$76K Buy
63,843
+24,414
+62% +$33.2K 0.01% 858
2024
Q1 		$40K Sell
39,429
-20,485
-34% -$17.2K ﹤0.01% 1057
2023
Q4 		$64K Buy
59,914
+40,952
+216% +$44.3K 0.01% 1133
2023
Q3 		$31K Buy
+18,962
New +$29.9K ﹤0.01% 954
2023
Q1 		– Sell
-18,379
Closed -$43K – 2052
2022
Q4 		$43K Buy
+18,379
New +$51.6K 0.01% 1113
2022
Q1 		– Sell
-13,935
Closed -$77K – 1989
2021
Q4 		$77K Buy
+13,935
New +$105K 0.01% 1227
2021
Q2 		– Sell
-14,593
Closed -$125K – 2029
2021
Q1 		$125K Sell
14,593
-4,855
-25% -$39.7K 0.01% 1244
2020
Q4 		$113K Buy
+19,448
New +$77.8K 0.01% 1028
2020
Q3 		– Sell
-33,296
Closed -$98K – 1468
2020
Q2 		$98K Buy
+33,296
New +$90.3K 0.01% 885
2018
Q3 		– Sell
-240
Closed -$41K – 2122
2018
Q2 		$41K Buy
240
+13
+6% +$3.56K ﹤0.01% 1792
2018
Q1 		$39K Buy
227
+211
+1,319% +$60.2K ﹤0.01% 1751
2017
Q4 		$6K Buy
16
+3
+23% +$1.45K ﹤0.01% 2280
2017
Q3 		$7K Buy
+13
New +$8.58K ﹤0.01% 2423

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial's SLS Position: Q2 2026 in Review

Virtu Financial sold out of SELLAS Life Sciences (SLS) in Q2 2026, closing a stake of 221,829 shares — an estimated $938K sold.

Virtu Financial first reported a position in SLS in Q3 2017 and held it in 17 quarters. The position peaked at $938K in Q1 2026. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Virtu Financial reported no remaining SELLAS Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 221,829 SELLAS Life Sciences shares in Q2 2026, an estimated $938K.
  • Virtu Financial first reported a position in SELLAS Life Sciences in Q3 2017 and held it in 17 quarters.
  • Virtu Financial's SELLAS Life Sciences position peaked at $938K in Q1 2026.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.